National Research (NRC) Scheduled to Post Earnings on Tuesday

National Research (NASDAQ:NRCGet Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 3rd. Parties that are interested in registering for the company’s conference call can do so using this link.

National Research (NASDAQ:NRCGet Rating) last issued its earnings results on Tuesday, February 8th. The company reported $0.38 earnings per share for the quarter. National Research had a return on equity of 47.12% and a net margin of 25.32%. The company had revenue of $38.30 million during the quarter.

Shares of NASDAQ NRC opened at $37.26 on Tuesday. National Research has a 1-year low of $36.29 and a 1-year high of $55.67. The stock has a 50-day moving average of $39.03. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.83 and a quick ratio of 1.82. The stock has a market capitalization of $938.73 million, a P/E ratio of 25.35 and a beta of 0.70.

The business also recently announced a quarterly dividend, which was paid on Friday, April 15th. Stockholders of record on Thursday, March 31st were given a $0.24 dividend. This is an increase from National Research’s previous quarterly dividend of $0.12. The ex-dividend date was Wednesday, March 30th. This represents a $0.96 annualized dividend and a dividend yield of 2.58%. National Research’s dividend payout ratio is presently 65.31%.

In related news, major shareholder Amandla Mk Trust sold 1,322 shares of the business’s stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $39.90, for a total value of $52,747.80. Following the transaction, the insider now owns 5,934,272 shares in the company, valued at $236,777,452.80. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In the last quarter, insiders sold 12,659 shares of company stock worth $512,379. Insiders own 4.20% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Glenmede Trust Co. NA raised its stake in National Research by 6.0% during the fourth quarter. Glenmede Trust Co. NA now owns 5,642 shares of the company’s stock valued at $234,000 after buying an additional 319 shares in the last quarter. California State Teachers Retirement System raised its stake in National Research by 2.2% during the fourth quarter. California State Teachers Retirement System now owns 19,437 shares of the company’s stock valued at $807,000 after buying an additional 426 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in National Research by 0.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 96,337 shares of the company’s stock valued at $4,000,000 after buying an additional 818 shares in the last quarter. Morgan Stanley raised its stake in National Research by 7.3% during the second quarter. Morgan Stanley now owns 17,000 shares of the company’s stock valued at $780,000 after buying an additional 1,155 shares in the last quarter. Finally, Invesco Ltd. raised its stake in National Research by 10.6% during the third quarter. Invesco Ltd. now owns 15,800 shares of the company’s stock valued at $666,000 after buying an additional 1,514 shares in the last quarter. Hedge funds and other institutional investors own 68.68% of the company’s stock.

Separately, TheStreet cut National Research from a “b-” rating to a “c+” rating in a research note on Tuesday, January 18th.

National Research Company Profile (Get Rating)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

Featured Stories

Earnings History for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.